|
⚲
|
| Piedmont Pharmaceuticals LLC | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001165139 |
| Sale | 2009-03-17 ($5.2 M Offered, $5.2 M Sold) |
| Fund | |
| Phone | 3365440320 |
| Address | 204 Muirs Chapel Road Greensboro, 27410 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Andy Jane | |
| Kenneth Yates | |
| Thomas Sloan | |
| Roland Johnson | |
| Luther Hodges Jr |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
BookSniffer Inc
✚
|
0.0 | |
|
Ardevora Asset Management LLP
✚
|
0.0 | |
|
Venrock Partners Management V, LLC
✚
|
0.0 | |
|
Westfield Gateway 2015, LLC
✚
|
0.0 | |
|
First International Bancshares Inc
✚
|
0.0 | |
|
First Trust Senior Floating Rate 2022 Target Term Fund
✚
|
0.0 | |
|
Football Investment Fund LP
✚
|
0.0 | |
|
FOR Fund I, a series of Moving Capital, LP
✚
|
0.0 | |
|
FOR Fund I, a series of Sajid Rahman Angel Funds, LP
✚
|
0.0 | |
|
Regal Funds Management PTY Ltd
✚
|
0.0 |